Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
Public ClinicalTrials.gov record NCT00048776. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Juvenile secondary Raynaud's (ray-knows) Phenomenon is a disorder of the blood vessels in the fingers and sometimes can affect the toes, nose, or ears. Children with secondary Raynaud's Phenomenon have an underlying condition such as systemic lupus, scleroderma, or mixed connective tissue disease. When children with secondary Raynaud's are exposed to chilly or cold conditions from weather, cold temperatures, or even holding cold items from the refrigerator, their fingers may become cold, numb, hurt, and/or turn purple or white. The investigational drug, Pletal(cilostazol), which has been approved for other conditions, inhibits the ability of one type of blood cell, platelets, to form blood clots, and also widens narrowed blood vessels. It has been used in a variety of other conditions in which blood flow is decreased. This study will test the safety and effectiveness Pletal(cilostazol) to lessen the severity of the symptoms and decrease the number of secondary Raynaud's episodes in juvenile patients.
Study identification
- NCT ID
- NCT00048776
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 5 Years to 16 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2001 (Type not available)
- Primary completion
- Not listed
- Completion
- Jun 2003 (Type not available)
- Last update posted
- Jul 19, 2005
2001 – 2003
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Medical Clinical Therapeutics | Anchorage | Alaska | 99508 | — |
| Advanced Medical Research Institute | Fresno | California | 93710 | — |
| Madera Family Medical Group | Madera | California | 93637 | — |
| Connecticut Children's Medical Center | Hartford | Connecticut | 06106 | — |
| LaRabida Children's Hospital | Chicago | Illinois | 60649 | — |
| Children's Hospital Boston | Boston | Massachusetts | 02115 | — |
| St. Louis University Health Sciences Center | St Louis | Missouri | 63104 | — |
| Children's Hospital | Omaha | Nebraska | 68114 | — |
| Asthma & Allergy Research Center | Newark | New Jersey | 07103 | — |
| SUNY Downstate Medical Center | Brooklyn | New York | 11203 | — |
| Children's Hospital of Buffalo | Buffalo | New York | 14222 | — |
| Schneider Children's Hospital | New Hyde Park | New York | 11040 | — |
| New York Medical College | Valhalla | New York | 10595 | — |
| Jobst Vascular Center | Toledo | Ohio | 43606 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| The Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Monarch Research Associates | Norfolk | Virginia | 23510 | — |
| Children's Hospital and Regional Medical Center | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00048776, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2005 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00048776 live on ClinicalTrials.gov.